A9BR99 AF NFT

DNA-directed RNA polymerase subunit beta'

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiab37ccm55ne5kxm5yeu6yodgq7bqrp63eudr5y54zgmy6566cndm/metadata.json
IPFS of structure file: 
bafybeihva5ezdriu2hfundlxicjoqayj2laozwqe6oj67dxhpnkui3mzum/AF-A9BR99-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x78Cc7f9BF18AF8279e492D45EE7Fe9d7cC6f6D07
First NFT owner address (bech32): 
genesis10rx8lxl33tuz08jf94z7ullf6lxx7mg8844d65
Current NFT ID #388348 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
388348
Accession (UniProt):
A9BR99
Name::
DNA-directed RNA polymerase subunit beta'
Experimental Method:
Predicted structure
Sequence source:
Delftia acidovorans (strain DSM 14801 / SPH-1)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A9BR99 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A9BR99|RPOC_DELAS DNA-directed RNA polymerase subunit beta' OS=Delftia acidovorans (strain DSM 14801 / SPH-1) OX=398578 GN=rpoC PE=3 SV=1 MKSLLDLFKQFTPDEHFDAIKIGLASPEKIRSWSFGEVKKPETINYRTFKPERDGLFCAKIFGPIKDYECLCGKYKRLKHRGVICEKCGVEVTQTKVRRERMGHIDLAAPCAHIWFLKSLPSRLGLVLDMTLRDIERVLYFEAYVVTDPGMTPLKKFSIMTEDDYEAKRTEYGDEFEAKMGAEGIKDLLEGIDIDVETERLRGDLTGSEVKVKKNAKRLKLLEAFKKSGIKPGWMVMEVLPVLPPDLRPLVPLDGGRFATSDLNDLYRRVINRNSRLRRLLELKAPEIIARNEKRMLQEAVDSLLDNGRRGKAMTGANKRALKSLADMIKGKSGRFRQNLLGKRVDYSGRSVITVGPYLKLHQCGLPKLMALELFKPFIFAQLEQRGIATTIKAAKKEVESGTPVVWDILEEVIKEHPVMLNRAPTLHRLGIQAFEPILIEGKAIQLHPLVCAAFNADFDGDQMAVHVPLSVEAQMEARTLMLASNNVLFPASGEPSIVPSQDVVLGLYHATRERINGKGEGMIFADIGEVQRALDSDQVELAAKISVRLTEWTKNKDSGEFEPSTSLVETTVGRALMSEILPKGLPFSHMNKALKKKEISKLINASFRKCGLKATVVFADKLLQNGFRLSTHAGISIAIGDMLVPPQKAEIIGRAEAEVKEIEQQYVSGLVTAGERYNKVVDIWGKAGDEVSKVMMAQLAKEKVIDRHGNEVEQESFNAIYMMADSGARGSAAQIRQLAGMRGLMAKPDGSIIETPITANFREGLNVLQYFISTHGARKGLADTALKTANSGYLTRRLVDVTQDLVVNEDDCGTTNGALMRAIVEGGEVIESLRDRVLGRTTAEDVVHPETLAVLLPAGTLLNEDGIDELELQGVDEIKVRTALTCETRYGLCAKCYGRDLGRGGLINLGEAVGVIAAQSIGEPGTQLTMRTFHIGGAASRAAIASSVEAKSNGSISFNSTMRYVSNTKGELVVISRSGEIVISDNGRERERHKVPYGAVLTVRPDQQVKAGLILANWDPLTRPIITEYAGQVRFENVEEGLTVAKQVDEVTGLSTLVVIDPKRRGSAKVVRPQVKLIDANNQEVKIPGTDHSVTIGFQVGALIQVRDGQDVGPGEVLARIPVEGQKTRDITGGLPRVAELFEARTPKDKGTLAEMTGTISFGKETKGKVRMQITDLDGKVWEELVPKEKNILVHEGQVVNKGESIVDGPADPQDILRLLGIEELSRYIVDEVQDVYRLQGVKINDKHIEVIVRQMLRRVVVENTGDSTYIAGEQVERSEILNTNEALQREGKIPATYSNVLLGITKASLSTDSFISAASFQETTRVLTEAAIMGKRDELRGLKENVIVGRLIPAGTGLAYHQARKAKDAMDDAERRAIADAEAAELAGVMADDDTAAVSVAGDASAD